IP Rights

• Patent for manufacturing platform of Liposomal Cisplatin has become outside of patent protection by 2019 that allows LIPOTECH to manufacture Liposomal Ciplatin under GMP Certified Facility of ForDoz Pharma in New Jersey
• LIPOTECH started co-development of new liposomal oncology drugs with patent protection for 20 years
• The inhalation chemotherapy applications in Rutgers University has the patent protection till 2035

NANOTECHNOLOGY APPROACH FOR INHALATION THERAPIES

Patent number : 9445993

Abstract : This invention relates to lipid nanoparticle

compositions and methods for the localized delivery of active agents via inhalation therapy.

Type : Grant

Filed : April 16, 2013

Date of Patent : September 20, 2016

Assignee : Rutgers, The State University of New Jersey

Inventors : Tamara Minko, Olga B. Garbuzenko, Vera Ivanova

COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACID MOLECULES AND TREATING CANCER

Patent number : 9289505

Abstract : The present invention provides compositions and methods for the delivery of nucleic acids to a cell. The present invention additionally provides compositions and methods for the treatment of a disease or disorder, particularly cancer. In a particular embodiment, the composition comprises at least one pharmaceutically acceptable carrier and at least one liposome or dendrimer comprising at least two chemotherapeutic agents with different mechanisms of action and at least two inhibitors of cellular drug resistance.

Type : Grant

Filed : August 17, 2011

Date of Patent : March 22, 2016

Assignee : Rutgers, The State University of New Jersey

Inventors : Tamara Minko, Lorna Rodriguez-Rodriguez, Olga B. Garbuzenko, Oleh Taratula, Vatsal Shah